Gamified Attention Bias Modification for Depression

Phase-Based Progress Estimates
Mary Eileen McNamara, Austin, TXDepressionGamified Attention Bias Modification - Device
18 - 45
All Sexes
What conditions do you have?

Study Summary

This trial tests a digital intervention to reduce depression and rumination in individuals with elevated symptoms. Participants use the intervention for 4 weeks & complete daily & weekly surveys.

Eligible Conditions
  • Depression

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: daily over 4 weeks

Week 4
Patient Health Questionnaire - 8 (PHQ-8)
Perseverative Thinking Questionnaire (PTQ) -"Difficult to Disengage from" subscale
Ruminative Response Scale - Brooding subscale (RRS-B)
Week 4
Attention bias (mousetracking)
daily over 4 weeks
General Rumination

Trial Safety

Trial Design

2 Treatment Groups

Gamified Attention Bias Modification
1 of 2
Gamified Placebo Training
1 of 2

Active Control

Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Gamified Attention Bias Modification · Has Placebo Group · N/A

Gamified Attention Bias Modification
ActiveComparator Group · 1 Intervention: Gamified Attention Bias Modification · Intervention Types: Device
Gamified Placebo Training
ShamComparator Group · 1 Intervention: Gamified Placebo Training · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: daily over 4 weeks

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
296 Previous Clinical Trials
67,818 Total Patients Enrolled
22 Trials studying Depression
3,329 Patients Enrolled for Depression

Eligibility Criteria

Age 18 - 45 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must have normal vision or be able to correct your vision to normal with glasses or contact lenses.

Frequently Asked Questions

Is there still an opportunity to join this research endeavor?

"Per, this medical trial has ceased accepting participants - the initial posting of which was on September 1st 2023 and its last update occurring in November 30th 2022. At present, there are 1290 other trials available that require recruitment of patients." - Anonymous Online Contributor

Unverified Answer

Who has the potential to partake in this research endeavor?

"This medical trial is seeking to enrol 100 individuals with depressive symptoms aged between 18-45. To be considered, applicants must have normal or corrected vision; proficient English language skills; PHQ-8 rating of 10+; an attention bias task score higher than 6500 ms on sad faces; remain stable on any psychiatric and neurological medication they are taking; access to a smartphone for downloading the app and a laptop/desktop device to complete weekly assessments. These criteria should all be met in order for potential participants to provide informed consent." - Anonymous Online Contributor

Unverified Answer

Are individuals over 40 years of age being considered for this trial?

"As per the trial requirements, only adults between 18 and 45 are eligible to participate." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.